Mi az ára Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762)

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762) ára $1.15

Mi a Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762 piaci tőkésítése)

Chunghwa Chemical Synthesis & Biotech Co., Ltd. piaci tőkésítése (1762) $88.79M

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762) Bevétel

Based in New Taipei City, Taiwan, Chunghwa Chemical Synthesis & Biotech Co., Ltd., established in 1964 and previously known as China Chemical Synthesis Industry Co., Ltd., specializes in the development, production, and distribution of active pharmaceutical ingredients (APIs). The company's market reach includes Taiwan and the United States. Their API portfolio encompasses products designed for immunosuppression, oncology, and cardiovascular conditions, in addition to various peptide compounds. Moreover, they manufacture a wide array of bulk pharmaceutical substances for numerous therapeutic applications, including anti-anxiety agents, antidiabetics, laxatives, antifungals, antihistamines, antiseptics, antiulcerants, cardiovascular medications, skeletal muscle relaxants, hypolipidemics, antineoplastics, antihyperlipidemics, and immunosuppressants. Complementing its product offerings, Chunghwa Chemical Synthesis & Biotech delivers bespoke research and development as well as contract manufacturing services to both emerging drug developers and established generic pharmaceutical firms.

Év	Bevétel	Változtassa meg
Nincs elég adat a megadott dátumokhoz.

Év

Bevétel

Változtassa meg

Nincs elég adat a megadott dátumokhoz.

Vállalat	Bevétel	Bevételkülönbség	Ország
Royalty Pharma plc RPRX.US	$2.54B	-	US
Swedish Orphan Biovitrum AB SOBI.ST	-	-	SE
Ipsen S.A. IPN.PA	-	-	FR
Corcept Therapeutics Incorporated CORT.US	$830.81M	-	US
Recordati Industria Chimica e Farmaceutica S.p.A. REC.MI	-	-	IT

Vállalat

Bevétel

Bevételkülönbség

Ország